Comerica Securities’s Quest Diagnostics DGX Stock Holding History

Comerica Securities’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$368K	Sell	3,018 -3,135	-51%	-$418K	0.03%	325
2023 Q2	$865K	Hold	6,153	–	–	0.06%	244
2023 Q1	$871K	Hold	6,153	–	–	0.06%	240
2022 Q4	$963K	Buy	6,153 +243	+4%	+$34.9K	0.07%	241
2022 Q3	$725K	Sell	5,910 -73	-1%	-$9.61K	0.06%	247
2022 Q2	$796K	Buy	5,983 +178	+3%	+$24.3K	0.06%	250
2022 Q1	$794K	Hold	5,805	–	–	0.05%	268
2021 Q4	$1M	Hold	5,805	–	–	0.06%	236
2021 Q3	$844K	Hold	5,805	–	–	0.06%	259
2021 Q2	$766K	Hold	5,805	–	–	0.06%	259
2021 Q1	$745K	Sell	5,805 -66	-1%	-$8.13K	0.06%	256
2020 Q4	$700K	Sell	5,871 -65	-1%	-$7.92K	0.06%	251
2020 Q3	$680K	Hold	5,936	–	–	0.06%	236
2020 Q2	$676K	Buy	5,936 +193	+3%	+$20.5K	0.06%	234
2020 Q1	$461K	Buy	+5,743	New	+$595K	0.05%	255

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Comerica Securities's DGX Position: Q3 2023 in Review

Comerica Securities reduced its Quest Diagnostics (DGX) stake by 51% in Q3 2023, selling an estimated $418K and leaving 3,018 shares worth $368K. The position accounts for 0.03% of the portfolio, ranked #325.

Comerica Securities first reported a position in DGX in Q1 2020 and has held it in 15 quarters since. The position peaked at $1M in Q4 2021. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

Comerica Securities held 3,018 shares of Quest Diagnostics worth $368K as of Q3 2023.
Comerica Securities sold 3,135 Quest Diagnostics shares in Q3 2023, an estimated $418K.
Quest Diagnostics made up 0.03% of Comerica Securities's portfolio in Q3 2023, its #325 holding.
Comerica Securities first reported a position in Quest Diagnostics in Q1 2020 and has held it in 15 quarters since.
Comerica Securities's Quest Diagnostics position peaked at $1M in Q4 2021.
794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.